Xylem Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value decreased by 43.1% to $29.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 23.7%, from $38.00M to $29.00M. This is a positive signal — lower values indicate better performance for this metric.
Higher values indicate that a significant portion of vested options are 'in-the-money,' which may lead to imminent share issuance.
This metric represents the aggregate intrinsic value of all vested and exercisable stock options. It measures the immedi...
Standard metric for assessing the immediate value of vested employee equity.
other_sharebased_compensation_arrangement_by_sharebased__feb020| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $98.00M | $89.00M | $41.00M | $30.00M | $41.00M | $59.00M | $108.00M | $64.00M | $70.00M | $55.00M | $52.00M | $38.00M | $42.00M | $51.00M | $29.00M |
| QoQ Change | — | -9.2% | -53.9% | -26.8% | +36.7% | +43.9% | +83.1% | -40.7% | +9.4% | -21.4% | -5.5% | -26.9% | +10.5% | +21.4% | -43.1% |
| YoY Change | — | — | — | -69.4% | -53.9% | +43.9% | +260.0% | +56.1% | +18.6% | -49.1% | -18.8% | -45.7% | -23.6% | -1.9% | -23.7% |